Jade Biosciences, Inc. · NASDAQ:JBIO
Sofinnova Venture Partners X, L.P. ("SVP X") reported a 0.30% stake in Jade Biosciences, Inc. (Schedule 13D/A)
Event Apr 28, 2025 · Filed Mar 5, 2026
Sofinnova Venture Partners X, L.P. ("SVP X") reported a 0.30% stake in Jade Biosciences, Inc., 107,391 shares, with active intent on Apr 28, 2025. Filed Mar 5, 2026 (Schedule 13D/A).
- Stake
- 0.30%
- Shares
- 107,391
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sofinnova Venture Partners X, L.P. ("SVP X") | 0.30% | 107,391 |
| Sofinnova Management X, L.P. ("SM X LP") | 0.30% | 107,391 |
| Sofinnova Management X-A, L.L.C. ("SM X LLC") | 0.30% | 107,391 |
| Dr. James I. Healy ("Healy") | 0.30% | 107,391 |
| Dr. Maha Katabi ("Katabi") | 0.30% | 107,391 |
Source
Related
- Jade Biosciences, Inc.
- Sofinnova Venture Partners X, L.P. ("SVP X")
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026